0.00Open0.05Pre Close0 Volume865 Open Interest1.00Strike Price0.00Turnover4689.64%IV26.92%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier-7DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.1987Delta0.7220Gamma26.00Leverage Ratio-3.3907Theta0.0000Rho-5.17Eff Leverage0.0000Vega
Ocugen Stock Discussion
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients With Retinitis Pigmentosa
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in Gardian Study for Stargardt Disease
No comment yet